Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(5aS,8aS)-7-(tetrahydro-2H-pyran-4-yl)-3-(4-(trifluoromethyl)phenyl)-4,5a,6,7,8,8a-hexahydropyrrolo[3,4-b][1,2,3]triazolo[1,5-d][1,4]oxazine
ID: ALA5202041
PubChem CID: 168291610
Max Phase: Preclinical
Molecular Formula: C19H21F3N4O2
Molecular Weight: 394.40
Associated Items:
This compound is not in our inventory system